US2981641A - Tobacco products - Google Patents
Tobacco products Download PDFInfo
- Publication number
- US2981641A US2981641A US3718A US371860A US2981641A US 2981641 A US2981641 A US 2981641A US 3718 A US3718 A US 3718A US 371860 A US371860 A US 371860A US 2981641 A US2981641 A US 2981641A
- Authority
- US
- United States
- Prior art keywords
- tobacco
- nicotine
- nornicotine
- salt
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
- A24B15/38—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero atom
Definitions
- the present invention is concerned with treated tobacco products. In particular, it deals with tobacco in which there has been incorporated a compound which is an antagonist for nicotine and which has a particular chemical structure.
- the compounds useful in the present invention as antagonists for nicotine are chemically related to nicotine itself,- but they differ from nicotine in that the methyl group present on the nitrogen atom in the -membered ring of nicotine has been replaced by a lower alkyl group containing from 2 to 8 carbon atoms.
- suitable alkyl groups there may be mentioned the ethyl group, the propyl group, the isopropyl group, the hexyl group, the isobutyl group, the octyl group and the allyl group.
- the antagonist may be used in the form of a free base, but it is preferred to use it in the form of a salt of an acid. It is most preferred to use the antagonist as the salt of an organic acid, particularly an organic acid which naturally forms salts with nicotine in tobacco, e.g. citric acid and malic acid.
- compositions of the present invention are useful in assisting a smoker to break the tobacco habit.
- tobaccos treated in accordance with the present invention when burned in accordance with usual smoking practice, yield a smoke which contains vapors of the compound which is antagonistic to nicotine.
- the smoke provides the desired aroma and taste of smoke from conventional tobacco, but because of the antagonistic action of the additives, the physiological responses elicited by nicotine and related alkaloids naturally in tobacco are diminished. This diminished physiological response helps the smoker to stop smoking or to reduce the smoking habit.
- the nicotine antagonist which is in all cases a tertiary amine, is incorporated in the tobacco, preferably in the form of a salt with an organic acid with naturally occurs with nicotine in tobacco, for example citric and malic acids.
- a solution of the salt is sprayed on the tobacco prior to the final processing steps in which it is made into the usual forms such as cigarettes, cigars and pipe tobacco.
- the amount of antagonist to be incorporated in the tobacco is preferably of the same order of magnitude as the amount of nicotine present in the tobacco.
- Information pnblished in the scientific literature indicates that the amount of nicotine present in tobacco varies from 0.5 to 8.0%. In the case of cigarette tobacco, the usual range is from 0.7 to 3.0%, with about 1.5% being an average value.
- N-alkyl nornicotine compounds of the present invention are prepared by the reaction of nornicotine, which occurs naturally in tobacco, and the appropriate alkyl halide.
- the acid addition salts are prepared by simple reaction between the free base and an acid, for example, acetic acid, hydrochloric acid, sulfuric acid, phosphoric acid, citric acid and malic acid.
- Example 1 Tobacco leaves are sprayed with an aqueous solution of the citrate salt of N-allyl nornicotine, so that after drying, the tobacco contains 3% of the added material. The spraying operation is conducted so that the additive is uniformly distributed throughout the tobacco mass. The tobacco is then processed in the normal fashion, and made into cigarettes, cigars or pipe tobacco as desired.
- Smokers who substitute tobacco treated in accordance with the present invention for their normal conventional cigars, pipes or cigarettes experience the same desirable taste as with conventional tobacco, but also experience a decrease in the craving for tobacco. The subjects find that less will power is required in order to decrease or completely eliminate the smoking habit.
- Example 2 The procedure of Example 1 may be repeated except that in place of the citrate salt, the malic acid salt is used. In like manner, when in place of N-allyl nornicotine, N-ethyl nornicotine, Nhexyl nornicotine or N-octyl nornicotine is used, either in the form of the free base or an acid addition salt, similar results are obtained.
- the concentration of the additive may be varied from 0.5 to 8.0%.
- tobacco comprising from 0.5 to 8.0% of a compound selected from the group consisting of N-alkyl nornicotine compounds containing from 2 to 8 carbon atoms in the alkyl group, and acid addition salts thereof.
- tobacco comprising from 0.5 to 8.0% of an N-alkyl nornicotine compound containing from 2 to 8 carbon atoms in the alkyl group, said compound being present in the form of a salt of an organic acid which naturally forms a salt with nicotine in tobacco.
- tobacco comprising from 0.5 to 8.0% of N-allyl nornicotine in the form of a salt of an organic acid which naturally forms a salt with nicotine in tobacco.
- tobacco comprising from 0.7 to 3.0% of an N-alkyl nornicotine compound containing from 2 to 8 carbon atoms in the alkyl group, said compound being present in the form of a salt of an organic acid which naturally forms a salt with nicotine in tobacco.
- tobacco comprising from 0.7 to 3.0% of N-allyl nornicotine in the form of a salt of an organic acid which naturally'forms a salt with nicotine in tobacco.
- tobacco comprising from 0.5 to 8.0% of N-allyl nornicotine citrate.
- tobacco comprising from 0.7 to 3.0% of N-allyl nornicotine citrate.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plural Heterocyclic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
Description
TOBACCO PRODUCTS Robert C. ONeill, New York, N.Y., assignor to Stauifer Chemical Company, New York, N.Y., a corporation of Delaware No Drawing. Filed Jan. 21, 1960, Ser. No. 3,718
7 Claims. (Cl. 131-17) The present invention is concerned with treated tobacco products. In particular, it deals with tobacco in which there has been incorporated a compound which is an antagonist for nicotine and which has a particular chemical structure.
The compounds useful in the present invention as antagonists for nicotine are chemically related to nicotine itself,- but they differ from nicotine in that the methyl group present on the nitrogen atom in the -membered ring of nicotine has been replaced by a lower alkyl group containing from 2 to 8 carbon atoms. As examples of suitable alkyl groups there may be mentioned the ethyl group, the propyl group, the isopropyl group, the hexyl group, the isobutyl group, the octyl group and the allyl group.
The antagonist may be used in the form of a free base, but it is preferred to use it in the form of a salt of an acid. It is most preferred to use the antagonist as the salt of an organic acid, particularly an organic acid which naturally forms salts with nicotine in tobacco, e.g. citric acid and malic acid.
Many persons who smoke desire to break the smoking habit. The reasons for desiring to break the habit are many and varied, and may be based on advice from a physician or purely on economic considerations. In any case it has been the experience of numerous smokers, and particularly of very heavy smokers, that it is very difficult to give up the tobacco habit.
The compositions of the present invention are useful in assisting a smoker to break the tobacco habit. Tobaccos treated in accordance with the present invention, when burned in accordance with usual smoking practice, yield a smoke which contains vapors of the compound which is antagonistic to nicotine. The smoke provides the desired aroma and taste of smoke from conventional tobacco, but because of the antagonistic action of the additives, the physiological responses elicited by nicotine and related alkaloids naturally in tobacco are diminished. This diminished physiological response helps the smoker to stop smoking or to reduce the smoking habit.
In accordance with the present invention the nicotine antagonist, which is in all cases a tertiary amine, is incorporated in the tobacco, preferably in the form of a salt with an organic acid with naturally occurs with nicotine in tobacco, for example citric and malic acids. A solution of the salt is sprayed on the tobacco prior to the final processing steps in which it is made into the usual forms such as cigarettes, cigars and pipe tobacco. The amount of antagonist to be incorporated in the tobacco is preferably of the same order of magnitude as the amount of nicotine present in the tobacco. Information pnblished in the scientific literature indicates that the amount of nicotine present in tobacco varies from 0.5 to 8.0%. In the case of cigarette tobacco, the usual range is from 0.7 to 3.0%, with about 1.5% being an average value.
United ntates Patent The N-alkyl nornicotine compounds of the present invention are prepared by the reaction of nornicotine, which occurs naturally in tobacco, and the appropriate alkyl halide. The acid addition salts are prepared by simple reaction between the free base and an acid, for example, acetic acid, hydrochloric acid, sulfuric acid, phosphoric acid, citric acid and malic acid.
The following examples are given solely for the purposes of illustration and are not to be considered limitations of the invention, many variations of which will occur to those skilled in the art without departing from the spirit or scope thereof.
Example 1 Tobacco leaves are sprayed with an aqueous solution of the citrate salt of N-allyl nornicotine, so that after drying, the tobacco contains 3% of the added material. The spraying operation is conducted so that the additive is uniformly distributed throughout the tobacco mass. The tobacco is then processed in the normal fashion, and made into cigarettes, cigars or pipe tobacco as desired.
Smokers who substitute tobacco treated in accordance with the present invention for their normal conventional cigars, pipes or cigarettes experience the same desirable taste as with conventional tobacco, but also experience a decrease in the craving for tobacco. The subjects find that less will power is required in order to decrease or completely eliminate the smoking habit.
Example 2 The procedure of Example 1 may be repeated except that in place of the citrate salt, the malic acid salt is used. In like manner, when in place of N-allyl nornicotine, N-ethyl nornicotine, Nhexyl nornicotine or N-octyl nornicotine is used, either in the form of the free base or an acid addition salt, similar results are obtained. The concentration of the additive may be varied from 0.5 to 8.0%.
What is claimed is:
1. As a novel composition of matter, tobacco comprising from 0.5 to 8.0% of a compound selected from the group consisting of N-alkyl nornicotine compounds containing from 2 to 8 carbon atoms in the alkyl group, and acid addition salts thereof.
2. As a novel composition of matter, tobacco comprising from 0.5 to 8.0% of an N-alkyl nornicotine compound containing from 2 to 8 carbon atoms in the alkyl group, said compound being present in the form of a salt of an organic acid which naturally forms a salt with nicotine in tobacco.
3. As a novel composition of matter, tobacco comprising from 0.5 to 8.0% of N-allyl nornicotine in the form of a salt of an organic acid which naturally forms a salt with nicotine in tobacco.
4. As a novel composition of matter, tobacco comprising from 0.7 to 3.0% of an N-alkyl nornicotine compound containing from 2 to 8 carbon atoms in the alkyl group, said compound being present in the form of a salt of an organic acid which naturally forms a salt with nicotine in tobacco.
5. As a novel composition of matter, tobacco comprising from 0.7 to 3.0% of N-allyl nornicotine in the form of a salt of an organic acid which naturally'forms a salt with nicotine in tobacco.
6. As a novel composition of matter, tobacco comprising from 0.5 to 8.0% of N-allyl nornicotine citrate.
7. As a novel composition of matter, tobacco comprising from 0.7 to 3.0% of N-allyl nornicotine citrate.
No references cited.
Claims (1)
1. AS A NOVEL COMPOSITION OF MATTER, TOBACCO COMPRISING FROM 0.5 TO 8.0% OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OF N-ALKYL NORNICOTINE COMPOUNDS CONTAINING FROM 2 TO 8 CARBON ATOMS IN THE ALKYL GROUP, AND ACID ADDITION SALTS THEREOF.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3718A US2981641A (en) | 1960-01-21 | 1960-01-21 | Tobacco products |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3718A US2981641A (en) | 1960-01-21 | 1960-01-21 | Tobacco products |
Publications (1)
Publication Number | Publication Date |
---|---|
US2981641A true US2981641A (en) | 1961-04-25 |
Family
ID=21707244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US3718A Expired - Lifetime US2981641A (en) | 1960-01-21 | 1960-01-21 | Tobacco products |
Country Status (1)
Country | Link |
---|---|
US (1) | US2981641A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3071509A (en) * | 1961-03-09 | 1963-01-01 | Stauffer Chemical Co | N-alkyl-nornicotine:nicotine antagonist |
US4765348A (en) * | 1986-12-12 | 1988-08-23 | Brown & Williamson Tobacco Corporation | Non-combustible simulated cigarette device |
US5316759A (en) * | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
WO1996027303A1 (en) * | 1995-03-06 | 1996-09-12 | Lectec Corporation | Nicotine-free smoking material |
US5596007A (en) * | 1992-05-18 | 1997-01-21 | Pharmaco Behavioral Associates, Inc. | Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine |
US5612357A (en) * | 1992-05-18 | 1997-03-18 | Pharmaco Behavioral Associates, Inc. | Use of cotinine to assist in the cessation of tobacco smoking |
US20080233197A1 (en) * | 2006-06-19 | 2008-09-25 | Francis Joseph Matthews | Pharmaceutical compositions |
US20100151014A1 (en) * | 2008-12-16 | 2010-06-17 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
US20100152221A1 (en) * | 2007-12-17 | 2010-06-17 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
US20100266645A1 (en) * | 2007-12-17 | 2010-10-21 | Alfred Liang | Pharmaceutical compositions |
US20110014280A1 (en) * | 2002-09-20 | 2011-01-20 | Garth Boehm | Sequestering subunit and related compositions and methods |
-
1960
- 1960-01-21 US US3718A patent/US2981641A/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
None * |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3071509A (en) * | 1961-03-09 | 1963-01-01 | Stauffer Chemical Co | N-alkyl-nornicotine:nicotine antagonist |
US5316759A (en) * | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
US5574052A (en) * | 1986-03-17 | 1996-11-12 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
US5935975A (en) * | 1986-03-17 | 1999-08-10 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
US4765348A (en) * | 1986-12-12 | 1988-08-23 | Brown & Williamson Tobacco Corporation | Non-combustible simulated cigarette device |
US5596007A (en) * | 1992-05-18 | 1997-01-21 | Pharmaco Behavioral Associates, Inc. | Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine |
US5612357A (en) * | 1992-05-18 | 1997-03-18 | Pharmaco Behavioral Associates, Inc. | Use of cotinine to assist in the cessation of tobacco smoking |
WO1996027303A1 (en) * | 1995-03-06 | 1996-09-12 | Lectec Corporation | Nicotine-free smoking material |
US5880164A (en) * | 1995-03-06 | 1999-03-09 | Lectec Corporation | Nicotine-free smoking material |
US20110027455A1 (en) * | 2002-09-20 | 2011-02-03 | Garth Boehm | Sequestering subunit and related compositions and methods |
US20110014280A1 (en) * | 2002-09-20 | 2011-01-20 | Garth Boehm | Sequestering subunit and related compositions and methods |
US8685444B2 (en) | 2002-09-20 | 2014-04-01 | Alpharma Pharmaceuticals Llc | Sequestering subunit and related compositions and methods |
US8685443B2 (en) | 2002-09-20 | 2014-04-01 | Alpharma Pharmaceuticals Llc | Sequestering subunit and related compositions and methods |
US8158156B2 (en) | 2006-06-19 | 2012-04-17 | Alpharma Pharmaceuticals, Llc | Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist |
US20100143483A1 (en) * | 2006-06-19 | 2010-06-10 | Alpharma Pharmaceuticals, Llc. | Pharmaceutical compositions |
US20080233197A1 (en) * | 2006-06-19 | 2008-09-25 | Francis Joseph Matthews | Pharmaceutical compositions |
US20090162450A1 (en) * | 2006-06-19 | 2009-06-25 | Alpharma Pharmaceuticals, Llc. | Pharmaceutical composition |
US7682634B2 (en) | 2006-06-19 | 2010-03-23 | Alpharma Pharmaceuticals, Llc | Pharmaceutical compositions |
US7682633B2 (en) | 2006-06-19 | 2010-03-23 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
US8846104B2 (en) | 2006-06-19 | 2014-09-30 | Alpharma Pharmaceuticals Llc | Pharmaceutical compositions for the deterrence and/or prevention of abuse |
US8877247B2 (en) | 2006-06-19 | 2014-11-04 | Alpharma Pharmaceuticals Llc | Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist |
US20100152221A1 (en) * | 2007-12-17 | 2010-06-17 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
US20100266645A1 (en) * | 2007-12-17 | 2010-10-21 | Alfred Liang | Pharmaceutical compositions |
US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
US20100151014A1 (en) * | 2008-12-16 | 2010-06-17 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2981641A (en) | Tobacco products | |
DE1517311A1 (en) | Method and means for incorporating flavors into tobacco | |
WO1987006104A1 (en) | Improvements in and relating to tobacco products | |
EP0052969A3 (en) | Flavorant compounds, their pyrolysis products, and smoking and food compositions containing them | |
DE2356706A1 (en) | SMOKE MIXTURES | |
ATE7260T1 (en) | FLAVORING COMPOSITION FOR TOBACCO, PROCESS FOR PRODUCTION THEREOF AND TOBACCO PRODUCT CONTAINING SUCH COMPOSITION. | |
US3071509A (en) | N-alkyl-nornicotine:nicotine antagonist | |
US3136319A (en) | Smoking tobacco product having menthyl keto ester additive | |
US3890981A (en) | Novel process for altering the organoleptic properties of tobacco using one or more alpha-pyrones and process | |
US3782391A (en) | {62 -methylvaleric acid alkyl esters as tobacco flavorants | |
US3559656A (en) | Tobacco product | |
US3126012A (en) | Smqeong tobacco additives in the form | |
US3128772A (en) | Smoking tobacco additives in the form of menthyl ethers | |
US3112755A (en) | Tobacco product | |
EP0008299A4 (en) | Poly(isopropenyl esters) as carboxylic acid-release agents on tobacco. | |
US4183362A (en) | Decreasing the burn rate of smoking tobaccos | |
US3217716A (en) | Tobacco composition | |
US2872360A (en) | Tobacco | |
US2733174A (en) | Compositions containing monosodium | |
US3280824A (en) | Tobacco | |
US3381690A (en) | Tobacco product | |
US3124140A (en) | Tobacco and flavoring composition | |
US2392514A (en) | Adjunct for tobacco | |
CN111096476B (en) | Composite material, preparation method and application thereof | |
DE2309152A1 (en) | SMOKE MIXTURE |